These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

793 related articles for article (PubMed ID: 31231887)

  • 1. Silencing of long noncoding RNA HOXD-AS1 inhibits proliferation, cell cycle progression, migration and invasion of hepatocellular carcinoma cells through MEK/ERK pathway.
    Sun J; Guo Y; Bie B; Zhu M; Tian H; Tian J; Li J; Yang Y; Ji F; Kong G; Li Z
    J Cell Biochem; 2020 Jan; 121(1):443-457. PubMed ID: 31231887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.
    He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S
    J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The noncoding RNA HOXD-AS1 is a critical regulator of the metastasis and apoptosis phenotype in human hepatocellular carcinoma.
    Lu S; Zhou J; Sun Y; Li N; Miao M; Jiao B; Chen H
    Mol Cancer; 2017 Jul; 16(1):125. PubMed ID: 28724429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA LINC01503 promotes the progression of hepatocellular carcinoma via activating MAPK/ERK pathway.
    Wang MR; Fang D; Di MP; Guan JL; Wang G; Liu L; Sheng JQ; Tian DA; Li PY
    Int J Med Sci; 2020; 17(9):1224-1234. PubMed ID: 32547318
    [No Abstract]   [Full Text] [Related]  

  • 5. Silencing of long noncoding RNA LEF1-AS1 prevents the progression of hepatocellular carcinoma via the crosstalk with microRNA-136-5p/WNK1.
    Dong H; Jian P; Yu M; Wang L
    J Cell Physiol; 2020 Oct; 235(10):6548-6562. PubMed ID: 32068261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA LEF1-AS1 silencing diminishes EZH2 expression to delay hepatocellular carcinoma development by impairing CEBPB-interaction with CDCA7.
    Gao J; Dai C; Yu X; Yin XB; Zhou F
    Cell Cycle; 2020 Apr; 19(8):870-883. PubMed ID: 32178558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. lncRNA DRHC inhibits proliferation and invasion in hepatocellular carcinoma via c-Myb-regulated MEK/ERK signaling.
    Zhuang R; Zhang X; Lu D; Wang J; Zhuo J; Wei X; Ling Q; Xie H; Zheng S; Xu X
    Mol Carcinog; 2019 Mar; 58(3):366-375. PubMed ID: 30362626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
    Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
    Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-inducible long noncoding RNA NPSR1-AS1 promotes the proliferation and glycolysis of hepatocellular carcinoma cells by regulating the MAPK/ERK pathway.
    He H; Chen T; Mo H; Chen S; Liu Q; Guo C
    Biochem Biophys Res Commun; 2020 Dec; 533(4):886-892. PubMed ID: 33008585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA DCST1-AS1 accelerates the proliferation, metastasis and autophagy of hepatocellular carcinoma cell by AKT/mTOR signaling pathways.
    Li J; Zhai DS; Huang Q; Chen HL; Zhang Z; Tan QF
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6091-6104. PubMed ID: 31364110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Positive Feedback Loop of lncRNA HOXD-AS2 and SMYD3 Facilitates Hepatocellular Carcinoma Progression via the MEK/ERK Pathway.
    Sun J; Li Y; Shi M; Tian H; Li J; Zhu K; Guo Y; Mu Y; Geng J; Li Z
    J Hepatocell Carcinoma; 2023; 10():1237-1256. PubMed ID: 37533602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA HOXD-AS1 regulates proliferation of cervical cancer cells by activating Ras/ERK signaling pathway.
    Hu YC; Wang AM; Lu JK; Cen R; Liu LL
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5049-5055. PubMed ID: 29228418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear lncRNA HOXD-AS1 suppresses colorectal carcinoma growth and metastasis via inhibiting HOXD3-induced integrin β3 transcriptional activating and MAPK/AKT signalling.
    Yang MH; Zhao L; Wang L; Ou-Yang W; Hu SS; Li WL; Ai ML; Wang YQ; Han Y; Li TT; Ding YQ; Wang S
    Mol Cancer; 2019 Mar; 18(1):31. PubMed ID: 30823921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA MYLK-AS1 promotes growth and invasion of hepatocellular carcinoma through the EGFR/HER2-ERK1/2 signaling pathway.
    Liu J; Zhao SY; Jiang Q; Qu Y; Huang X; Du J; Sun W; Ye Q
    Int J Biol Sci; 2020; 16(11):1989-2000. PubMed ID: 32398965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The lncRNA
    Zhou N; Li S; Wu D; Zhang F; Tang F; Li Y
    DNA Cell Biol; 2021 Oct; 40(10):1278-1289. PubMed ID: 34558987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway.
    Li Y; Liu G; Li X; Dong H; Xiao W; Lu S
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2826-2832. PubMed ID: 30115383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HBx-related long non-coding RNA DBH-AS1 promotes cell proliferation and survival by activating MAPK signaling in hepatocellular carcinoma.
    Huang JL; Ren TY; Cao SW; Zheng SH; Hu XM; Hu YW; Lin L; Chen J; Zheng L; Wang Q
    Oncotarget; 2015 Oct; 6(32):33791-804. PubMed ID: 26393879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA FLVCR1-AS1 acts as miR-513c sponge to modulate cancer cell proliferation, migration, and invasion in hepatocellular carcinoma.
    Zhang K; Zhao Z; Yu J; Chen W; Xu Q; Chen L
    J Cell Biochem; 2018 Jul; 119(7):6045-6056. PubMed ID: 29574975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. lncRNA A1BG-AS1 suppresses proliferation and invasion of hepatocellular carcinoma cells by targeting miR-216a-5p.
    Bai J; Yao B; Wang L; Sun L; Chen T; Liu R; Yin G; Xu Q; Yang W
    J Cell Biochem; 2019 Jun; 120(6):10310-10322. PubMed ID: 30556161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ZSCAN16-AS1 expedites hepatocellular carcinoma progression via modulating the miR-181c-5p/SPAG9 axis to activate the JNK pathway.
    Liu J; Liu R; Liu Y; Li L; Cao H; Liu J; Cao G
    Cell Cycle; 2021 Jun; 20(12):1134-1146. PubMed ID: 34097562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.